Advertisement

Supply Chain

Atorvastatin calcium makes up 2.8 percent of outpatient prescription medication claims, according to a Dec. 30 report from Definitive Healthcare. 

Valencia, Calif.-based Advanced Biologics has agreed to pay over $12 million for allegedly violating the False Claims Act by misleading federal programs regarding radio-frequency emissions generated by cochlear implants, according to a Dec. 20 report from the Justice Department.

Case numbers have long recovered since the onset of the COVID-19 pandemic, but ASC leaders are still struggling with supply costs as they compete for contracts with the deep pockets of hospitals and health systems. 

Advertisement
Advertisement
Advertisement